Johns Hopkins scientists believe two genes could serve as reliable epigenetic biomarkers for postpartum depression.
Another team of researchers is tackling the task of developing a blood test designed to predict a patient's likelihood of suffering a heart attack. And they've zeroed on three promising biomarkers to help get the job done.
The hormone adrenomedullin is secreted by the fetus during pregnancy and appears to keep pregnant women from developing preeclampsia. And they believe it could become an effective biomarker to help pinpoint patients more likely to develop the dangerous condition.
An experimental drug designed to block an overactive protein in kidney cancer may provide a more targeted approach to treating the common cancer and could eventually be used as a therapy for other types of the disease.
Scientists at the University of Illinois have used the Cancer Genome Atlas to pinpoint dozens of biomarkers that can gauge a patient's survival prospects with ovarian cancer and also predict when the cancer might return.
A global research effort has identified a wide variety of biomarkers that point to the risk of developing schizophrenia. The discovery, led by experts at the Virginia Commonwealth University School of Pharmacy, gives scientists a whole slew of potential new targets for drug treatment.
Scanning the field of biomarker research for cardiovascular disease, a group of investigators has found some compelling data that suggest the effect of the biomarkers is regularly exaggerated, with signs of bias in the reports. And that clearly could be hurting the medical field's understanding of the biomarkers' significance.
European scientists may have discovered the molecular processes involved in the early stages of Parkinson's disease--a clue that could be used to develop new treatments to counteract early Parkinson's cellular changes.
Their initial study involved spotting human blood biomarkers for neuromyelitis optica, an autoimmune disorder that is similar to multiple sclerosis and makes sufferers go blind and become paralyzed.
Researchers at the Sanford-Burnham Medical Research Institute in La Jolla, CA, have discovered a specific protein that helps prostate cancer cells become resistant to hormone therapy, which could provide a new therapeutic window for improved treatment regimens.